Patents by Inventor Liuwei Song

Liuwei Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDE ENCODED BY EB VIRUS BNLF2B GENE AND USE THEREOF IN DETECTION
    Publication number: 20230324396
    Abstract: Provided are a method for diagnosing nasopharyngeal carcinoma on the basis of the anti-EB virus (EBV) antibody level and a kit used for the method. Also provided are a polypeptide encoded by a BNLF2b gene in EB virus used for the above-mentioned diagnosis and the use thereof for diagnosing nasopharyngeal carcinoma.
    Type: Application
    Filed: December 25, 2020
    Publication date: October 12, 2023
    Applicants: XIAMEN UNIVERSITY, XIAMEN INNODX BIOTECH CO., LTD, BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
    Inventors: Tingdong LI, Shengxiang GE, Xiaoyi GUO, Congming HONG, Liuwei SONG, Shunhua WEN, Jiabao TANG, Jun ZHANG, Ningshao XIA
  • METHOD AND ANTIBODY FOR DETECTION OF HBCAG
    Publication number: 20230069418
    Abstract: In the field of Hepatitis B virus (HBV) detection, disclosed are a method for detecting HBcAg by means of using a double antibody sandwich method, and an antibody and kit for detecting HBcAg; also included is a monoclonal antibody that can be used in the immunological detection of HBcAg in a tissue or cell sample.
    Type: Application
    Filed: January 18, 2021
    Publication date: March 2, 2023
    Inventors: Zimin CHEN, Junhui XIONG, Jiaqi LIU, Shaojuan WANG, Shengxiang GE, Quan YUAN, Liuwei SONG, Xudong SUN
  • Kit and method for quantitative detection of HBsAg
    Patent number: 11543413
    Abstract: A kit for quantitatively detecting HBsAg and a method for quantitatively detecting an HBsAg content in a sample containing HBsAg. The kit comprises a first antibody specifically binding to HBsAg and a reagent composition. The reagent composition comprises tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: January 3, 2023
    Assignees: XIAMEN INNODX BIOTECH CO., LTD, XIAMEN UNIVERSITY
    Inventors: Shunhua Wen, Liuwei Song, Zuxing Weng, Haijun Lin, Feihai Xu, Xudong Sun, Shengxiang Ge
  • SPECIFIC ANTIBODY AGAINST HUMAN ANTI-MULLERIAN HORMONE AND APPLICATION THEREOF
    Publication number: 20220146515
    Abstract: The present invention belongs to the field of biomedical laboratory science, and provides a specific antibody for AMH and uses thereof.
    Type: Application
    Filed: November 6, 2019
    Publication date: May 12, 2022
    Inventors: Junhui XIONG, Zimin CHEN, Weiling XU, Long WANG, Qishen KE, Lihua LI, Liuwei SONG, Xudong SUN, Shengxiang GE
  • A kit and method for quantitative detection of HBsAg
    Publication number: 20210164981
    Abstract: A kit for quantitatively detecting HBsAg and a method for quantitatively detecting an HBsAg content in a sample containing HBsAg. The kit comprises a first antibody specifically binding to HBsAg and a reagent composition. The reagent composition comprises tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 3, 2021
    Inventors: Shunhua WEN, Liuwei SONG, Zuxing WENG, Haijun LIN, Feihai XU, Xudong SUN, Shengxiang GE
  • Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect
    Patent number: 9952217
    Abstract: The present invention relates to a method for quantitative detection of anti-HBc and its use in monitoring disease progression of chronic hepatitis B patients and predicting therapeutic effects. By quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), it is able to monitor disease progression of chronic hepatitis B patients, effectively predict therapeutic effects in chronic hepatitis B patients who accept a therapy against hepatitis B virus (especially, a therapy based on interferon and a therapy based on nucleoside/nucleotide analog anti-HBV drug), and thus guide the patients to reasonably choose drugs.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: April 24, 2018
    Assignees: Xiamen Innovax Biotech, Co., LTD., Xiamen University
    Inventors: Quan Yuan, Liuwei Song, Wenbin Zhou, Zuxing Weng, Feihai Xu, Shengxiang Ge, Jun Zhang, Ningshao Xia
  • ANTI-HBC QUANTITATIVE DETECTION METHOD AND USES THEREOF IN MONITORING AND CONTROLLING DISEASE PROGRESSION OF CHRONIC HEPATITIS B PATIENT AND IN PREDICTING THERAPEUTIC EFFECT
    Publication number: 20150118674
    Abstract: The present invention relates to a method for quantitative detection of anti-HBc and its use in monitoring disease progression of chronic hepatitis B patients and predicting therapeutic effects. By quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), it is able to monitor disease progression of chronic hepatitis B patients, effectively predict therapeutic effects in chronic hepatitis B patients who accept a therapy against hepatitis B virus (especially, a therapy based on interferon and a therapy based on nucleoside/nucleotide analogue anti-HBV drug), and thus guide the patients to reasonably choose drugs.
    Type: Application
    Filed: January 17, 2013
    Publication date: April 30, 2015
    Inventors: Quan Yuan, Liuwei Song, Wenbin Zhou, Zuxing Weng, Feihai Xu, Shengxiang Ge, Jun Zhang, Ningshao Xia